[Treatment of essential hypertension with Sali-raufunction. Results of a clinical study].
D001581:Benzothiadiazines; D002301:Cardiac Glycosides / Q000627:therapeutic use; D004232:Diuretics; D004338:Drug Combinations; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D011188:Potassium / Q000627:therapeutic use; D046948:Secologanin Tryptamine Alkaloids / Q000627:therapeutic use; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use
D001581:Benzothiadiazines; D002301:Cardiac Glycosides; D004232:Diuretics; D004338:Drug Combinations; D046948:Secologanin Tryptamine Alkaloids; D049993:Sodium Chloride Symporter Inhibitors; D011188:Potassium
Die Behandlung der essentiellen Hypertonie mit Sali-Raufuncton.